Literature DB >> 3924182

Nephrotic syndrome during treatment with interferon.

K Sriskandan, D E Tee, K W Pettingale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3924182      PMCID： PMC1415737          DOI： 10.1136/bmj.290.6481.1590-d

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  1 in total

1.  A phase 1 study of recombinant interferon-gamma given intravenously by portable mini-pump: a preliminary report.

Authors:  K Sriskandan; P Garner; J Watkinson; L Gerlis; D E Tee
Journal:  Int J Clin Pharmacol Res       Date:  1984
  1 in total
  3 in total

1.  [Detection of nephrotoxicity of human alpha 2b interferon with special reference to the analysis of urine enzymes in patients with chronic myeloid leukemia].

Authors:  E Kurschel; U Metz-Kurschel; W Hofmann; N Niederle
Journal:  Klin Wochenschr       Date:  1987-07-15

Review 2.  Preclinical safety testing of species-specific proteins produced with recombinant DNA-techniques. An attempt to transfer current experience into future testing strategies.

Authors:  K Teelmann; C Hohbach; H Lehmann
Journal:  Arch Toxicol       Date:  1986-12       Impact factor: 5.153

Review 3.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.